Sprucegrove Investment Management Ltd. Raises Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Sprucegrove Investment Management Ltd. increased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 14.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 220,491 shares of the company's stock after acquiring an additional 27,500 shares during the quarter. Henry Schein comprises 0.7% of Sprucegrove Investment Management Ltd.'s investment portfolio, making the stock its 15th largest holding. Sprucegrove Investment Management Ltd. owned approximately 0.17% of Henry Schein worth $16,693,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Baystate Wealth Management LLC grew its holdings in Henry Schein by 2,500.0% during the 3rd quarter. Baystate Wealth Management LLC now owns 520 shares of the company's stock valued at $39,000 after buying an additional 500 shares in the last quarter. McGlone Suttner Wealth Management Inc. purchased a new position in Henry Schein during the 4th quarter valued at about $39,000. Neo Ivy Capital Management purchased a new position in Henry Schein during the 3rd quarter valued at about $46,000. Covestor Ltd grew its holdings in Henry Schein by 88.4% during the 1st quarter. Covestor Ltd now owns 861 shares of the company's stock valued at $75,000 after buying an additional 404 shares in the last quarter. Finally, RVW Wealth LLC purchased a new position in Henry Schein during the 3rd quarter valued at about $104,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

NASDAQ:HSIC traded down $0.80 during mid-day trading on Friday, reaching $71.01. The stock had a trading volume of 989,207 shares, compared to its average volume of 974,382. The firm has a 50 day moving average price of $74.81 and a two-hundred day moving average price of $72.57. The stock has a market capitalization of $9.12 billion, a P/E ratio of 22.54, a P/E/G ratio of 1.78 and a beta of 0.87. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $85.39. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts' consensus estimates of $0.70 by ($0.04). The firm had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business's quarterly revenue was down 10.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.21 EPS. As a group, analysts expect that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the business's stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares of the company's stock, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

HSIC has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lifted their target price on Henry Schein from $82.00 to $88.00 and gave the company an "overweight" rating in a report on Wednesday, March 6th. TheStreet upgraded Henry Schein from a "c+" rating to a "b-" rating in a research report on Monday, February 26th. Barrington Research lifted their price target on Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research report on Wednesday, February 28th. Jefferies Financial Group lifted their price target on Henry Schein from $74.00 to $81.00 and gave the company a "hold" rating in a research report on Wednesday, March 6th. Finally, Piper Sandler lifted their price target on Henry Schein from $78.00 to $86.00 and gave the company an "overweight" rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $81.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.